1
Kelly Michael G, Janagani Satyanarayana, Wu Guoxian, Kincaid John: Amide compounds as ion channel ligands and uses thereof. Renovis, Kelly Michael G, Janagani Satyanarayana, Wu Guoxian, Kincaid John, JACKSON David A, April 14, 2005: WO/2005/032493 (48 worldwide citation)

Compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammatio ...


2
Shishido Yuji, Nakao Kazunari, Nagayama Satoshi, Tanaka Hirotaka, Duncton Matthew Alexander James, Cox Matthew, Kincaid John, Sahasrabudhe Kiran, Estiarte Martinez Maria de Los Angeles: Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same. Renovis, Pfizer, Shishido Yuji, Nakao Kazunari, Nagayama Satoshi, Tanaka Hirotaka, Duncton Matthew Alexander James, Cox Matthew, Kincaid John, Sahasrabudhe Kiran, Estiarte Martinez Maria de Los Angeles, JACKSON David A, November 22, 2007: WO/2007/133637 (31 worldwide citation)

Compounds are disclosed that have a formula represented by the following: Formula (I). The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain ...


3
Kelly Michael G, Kincaid John, Kaub Carl J: Fused heterocyclic compounds, and compositions and uses thereof. Renovis, Kelly Michael G, Kincaid John, Kaub Carl J, ANTLER Adriane M, November 9, 2006: WO/2006/119504 (21 worldwide citation)

Fused heterocyclic compounds are disclosed that have formula (1): where A, B, L, N, R1, R3, R4', Y and Z are as defined herein. The compounds and pharmaceutical compositions thereof are useful for the prevention and treatment of a variety of conditions in mammals including humans, including by way o ...


4
Kelly Michael G, Kincaid John: Bicycloheteroaryl compounds as p2x7 modulators and uses thereof. Renovis, Kelly Michael G, Kincaid John, JACKSON David A, September 28, 2006: WO/2006/102588 (19 worldwide citation)

Bicycloheteroaryl compounds are disclosed that have a formula represented by the following: (I) The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting exam ...


5
Kelly Michael G, Kincaid John: Bicycloheteroaryl compounds as p2x7 modulators and uses thereof. Renovis, Kelly Michael G, Kincaid John, JACKSON David A, September 28, 2006: WO/2006/102610 (19 worldwide citation)

Bicycloheteroaryl compounds are disclosed that have a formula represented by the following: (I) The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting exam ...


6
Kelly Michael G, Kincaid John, Fang Yunfeng, Cao Yeyu, Kaub Carl, Gowlugari Sumithra: Bicycloheteroaryl compounds as p2x7 modulators and uses thereof. Renovis, Kelly Michael G, Kincaid John, Fang Yunfeng, Cao Yeyu, Kaub Carl, Gowlugari Sumithra, JACKSON David A, September 27, 2007: WO/2007/109160 (18 worldwide citation)

Bicycloheteroaryl compounds are disclosed that have formula (I). The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, trauma ...


7
Ouyang Xiaohu, Kiselyov Alexander, Chen Xiaoling, He Hai Ying, Kawakami Joel, Pattaropong Vatee, Piatnitski Evgueni, Tuma Maria Carolina, Kincaid John: Heterocyclic compounds and their use as anticancer agents. Imclone Systems Incorporated, Ouyang Xiaohu, Kiselyov Alexander, Chen Xiaoling, He Hai Ying, Kawakami Joel, Pattaropong Vatee, Piatnitski Evgueni, Tuma Maria Carolina, Kincaid John, SOMERVILLE Deborah A, January 20, 2005: WO/2005/004818 (17 worldwide citation)

The present invention relates to heterocyclic compounds that have anticancer activity, and pharmaceutical compositions that contain such compounds, methods of treating diseases and conditions in mammals using such compounds and composition and methods for their manufacture.


8
Kelly Michael G, Janagani Satyanarayana, Wu Guoxian, Kincaid John, Lonergan David, Fang Yunfeng, Wei Zhi Liang: Bicycloheteroarylamine compounds as ion channel ligands and uses thereof. Renovis, Kelly Michael G, Janagani Satyanarayana, Wu Guoxian, Kincaid John, Lonergan David, Fang Yunfeng, Wei Zhi Liang, JACKSON David A, July 21, 2005: WO/2005/066171 (12 worldwide citation)

Amine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, infla ...


9
Kelly Michael G, Kincaid John, Fang Yunfeng, Cao Yeyu, Kaub Carl, Gowlugari Sumithra, Wang Zhan: Bicycloheteroaryl compounds as p2x7 modulators and uses thereof. Renovis, Kelly Michael G, Kincaid John, Fang Yunfeng, Cao Yeyu, Kaub Carl, Gowlugari Sumithra, Wang Zhan, JACKSON David A, September 27, 2007: WO/2007/109192 (11 worldwide citation)

Bicycloheteroaryl compounds are disclosed that have a formula represented by the following formula (I): the compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limit ...


10
Kelly Michael G, Kincaid John, Fang Yunfeng, Cao Yeyu, Kaub Carl, Gowlugari Sumithra, Wang Zhan: Bicycloheteroaryl compounds as p2x7 modulators and uses thereof. Renovis, Kelly Michael G, Kincaid John, Fang Yunfeng, Cao Yeyu, Kaub Carl, Gowlugari Sumithra, Wang Zhan, JACKSON David A, September 27, 2007: WO/2007/109154 (10 worldwide citation)

Bicycloheteroaryl compounds are disclosed that have a formula represented by the following: Formula (I). The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limi ...